Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses

Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses

Item
http://www.wikidata.org/entity/Q37688266
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenA simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children.Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Antituberculosis drugs in children.A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children.Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications.Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy.Population Pharmacokinetics of the Antimalarial Amodiaquine: A Pooled Analysis to Optimize DosingExtrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale
P2860

Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses

Item
http://www.wikidata.org/entity/Q37688266
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population pharmacokinetics of ...... of currently recommended doses
@en
Population pharmacokinetics of ...... f currently recommended doses.
@nl
type
label
Population pharmacokinetics of ...... of currently recommended doses
@en
Population pharmacokinetics of ...... f currently recommended doses.
@nl
prefLabel
Population pharmacokinetics of ...... of currently recommended doses
@en
Population pharmacokinetics of ...... f currently recommended doses.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Population pharmacokinetics of ...... of currently recommended doses
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932